On Friday, Cogent Biosciences Inc (NASDAQ: COGT) was 6.55% up from the session before settling in for the closing price of $13.29. A 52-week range for COGT has been $3.72 – $13.55.
Annual sales at Healthcare sector company grew by 10.02% over the past five years. When this article was written, the company’s average yearly earnings per share was at 11.38%. With a float of $112.56 million, this company’s outstanding shares have now reached $113.93 million.
Cogent Biosciences Inc (COGT) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Cogent Biosciences Inc stocks. The insider ownership of Cogent Biosciences Inc is 19.43%, while institutional ownership is 87.34%. The most recent insider transaction that took place on Jul 10 ’25, was worth 24,999,993. In this transaction Director of this company bought 2,777,777 shares at a rate of $9.00, taking the stock ownership to the 9,003,418 shares. Before that another transaction happened on Jan 14 ’25, when Company’s Chief Commercial Officer bought 43,750 for $7.60, making the entire transaction worth $332,412. This insider now owns 45,848 shares in total.
Cogent Biosciences Inc (COGT) Performance Highlights and Predictions
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.64 earnings per share (EPS) during the time that was less than consensus figure (set at -0.57) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.5 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 11.38% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.50% during the next five years compared to 10.02% growth over the previous five years of trading.
Cogent Biosciences Inc (NASDAQ: COGT) Trading Performance Indicators
You can see what Cogent Biosciences Inc (COGT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.19.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.42, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -1.84 in one year’s time.
Technical Analysis of Cogent Biosciences Inc (COGT)
Cogent Biosciences Inc (NASDAQ: COGT) saw its 5-day average volume 1.64 million, a negative change from its year-to-date volume of 1.94 million. As of the previous 9 days, the stock’s Stochastic %D was 90.17%.
During the past 100 days, Cogent Biosciences Inc’s (COGT) raw stochastic average was set at 99.79%, which indicates a significant increase from 99.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.56 in the past 14 days, which was higher than the 0.54 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.19, while its 200-day Moving Average is $8.38. Nevertheless, the first resistance level for the watch stands at $14.46 in the near term. At $14.76, the stock is likely to face the second major resistance level. The third major resistance level sits at $15.34. If the price goes on to break the first support level at $13.58, it is likely to go to the next support level at $13.00. Assuming the price breaks the second support level, the third support level stands at $12.70.
Cogent Biosciences Inc (NASDAQ: COGT) Key Stats
There are 113,856K outstanding shares of the company, which has a market capitalization of 1.98 billion. As of now, sales total 0 K while income totals -255,860 K. Its latest quarter income was 0 K while its last quarter net income were -73,530 K.
